Propecia controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile2 entries
2024
Regulatory scrutiny of psychiatric effects
European regulators reviewed reports involving suicidal thoughts and other psychiatric effects associated with finasteride medicines, including products used for hair loss. The review concerned risk minimization and product information rather than a general withdrawal of finasteride.
2012
Persistent sexual side-effect controversy
Patient reports, scientific debate, and litigation focused on claims that sexual symptoms associated with finasteride could persist after treatment ended. U.S. labeling incorporated postmarketing information, while the frequency and causal mechanism of persistent symptoms remained contested.